Healthcare & Life Sciences
Kesmalea
United Kingdomkesmalea.com
Kesmalea is a startup based in the United Kingdom, most recent round Series A.
series-a
series-a
Stage
About Kesmalea
Kesmalea is a company headquartered in the United Kingdom. Its most recent tracked round is Series A.
Kesmalea develops novel small-molecule therapeutics using its SELFTAC® platform to create oral, CNS-penetrant targeted protein degraders for the treatment of oncology and central nervous system diseases.
Explore Kesmalea's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.